Liexi Xu

Tumor Microenvironment-based Gene Signatures Divides Novel Immune and Stromal Subgroup Classification of Lung Adenocarcinoma

C. Xie, Jiali Li, Z. Zeng, 2019, 1905.03978.

Downregulation of Nitric Oxide Collaborated with Radiotherapy to Promote Anti-Tumor Immune Response via Inducing CD8+ T Cell Infiltration

Yuan Luo, Yingming Sun, C. Xie, 2020, International journal of biological sciences.

Biomineralized Manganese Oxide Nanoparticles Synergistically Relieve Tumor Hypoxia and Activate Immune Response with Radiotherapy in Non-Small Cell Lung Cancer

Xinyu Liu, Yuzhou Wu, C. Xie, 2022, Nanomaterials.

Nanoscale Zeolitic Imidazolate Framework (ZIF)–8 in Cancer Theranostics: Current Challenges and Prospects

Mengqin Wang, Yuzhou Wu, C. Xie, 2022, Cancers.

SAMHD1 silencing cooperates with radiotherapy to enhance anti-tumor immunity through IFI16-STING pathway in lung adenocarcinoma

Jianguo Zhang, C. Xie, Xueping Jiang, 2022, Journal of Translational Medicine.

An integrative analysis of DNA methylation and gene expression to predict lung adenocarcinoma prognosis

C. Xie, Z. Zeng, Zhengrong Huang, 2022, Frontiers in Genetics.

Novel immune and stromal subtype classification system of lung adenocarcinoma based on tumor microenvironment

C. Xie, Jiali Li, Z. Zeng, 2019, bioRxiv.